FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2070795826> ?p ?o ?g. }

• W2070795826 endingPage "1815" @default.
• W2070795826 startingPage "1809" @default.
• W2070795826 abstract "Nicotine vaccines have shown preliminary evidence of efficacy for enhancing smoking cessation rates, but the serum nicotine-specific antibody (NicAb) concentrations produced are highly variable and many subjects do not develop effective levels. As an alternative to vaccination, passive immunization with nicotine-specific monoclonal antibodies could produce more uniform serum NicAb concentrations, but its use is limited by their high cost and shorter elimination half-life. This study investigated supplementing vaccination with monoclonal antibodies in a targeted fashion to increase vaccine efficacy while minimizing the required monoclonal antibody dose. Rats were vaccinated and then given individualized supplemental doses of the nicotine-specific monoclonal antibody Nic311 to achieve a target total serum NicAb concentration known to be effective for blocking locomotor sensitization (LMS) to nicotine. Rats received vaccine, Nic311, both, or neither, followed by 0.3 mg/kg nicotine s.c. for 10 days to produce LMS. Combination immunotherapy completely blocked the development of LMS, while monotherapy with vaccine or Nic311 alone was only minimally effective. Lower brain nicotine levels were associated with reduced locomotor activity averaged over days 7–10. Despite its greater efficacy, combination immunotherapy did not reduce the variability in the resulting total serum NicAb concentrations. Variability in total serum NicAb concentrations was contributed to by both vaccine-generated antibody and by Nic311. These data show that combination immunotherapy, using a Nic311 dose that is by itself only minimally effective, can substantially enhance nicotine vaccine efficacy. However, variability in serum NicAb levels with combination immunotherapy may make translation of this approach challenging." @default.
• W2070795826 created "2016-06-24" @default.
• W2070795826 creator A5006062404 @default.
• W2070795826 creator A5015161312 @default.
• W2070795826 creator A5024499904 @default.
• W2070795826 creator A5024624450 @default.
• W2070795826 creator A5029632579 @default.
• W2070795826 creator A5034179357 @default.
• W2070795826 creator A5051281767 @default.
• W2070795826 date "2011-11-01" @default.
• W2070795826 modified "2023-09-24" @default.
• W2070795826 title "Combined active and passive immunization against nicotine: Minimizing monoclonal antibody requirements using a target antibody concentration strategy" @default.
• W2070795826 cites W1963559996 @default.
• W2070795826 cites W1971966823 @default.
• W2070795826 cites W1987632529 @default.
• W2070795826 cites W1998805310 @default.
• W2070795826 cites W2001492607 @default.
• W2070795826 cites W2017295068 @default.
• W2070795826 cites W2017574768 @default.
• W2070795826 cites W2021583889 @default.
• W2070795826 cites W2029455707 @default.
• W2070795826 cites W2046002947 @default.
• W2070795826 cites W2048466545 @default.
• W2070795826 cites W2051268821 @default.
• W2070795826 cites W2051564096 @default.
• W2070795826 cites W2054127699 @default.
• W2070795826 cites W2061872647 @default.
• W2070795826 cites W2061888707 @default.
• W2070795826 cites W2069871552 @default.
• W2070795826 cites W2071904871 @default.
• W2070795826 cites W2074112763 @default.
• W2070795826 cites W2075128988 @default.
• W2070795826 cites W2093921560 @default.
• W2070795826 cites W2106425520 @default.
• W2070795826 cites W2106640050 @default.
• W2070795826 cites W2123951107 @default.
• W2070795826 cites W2130197019 @default.
• W2070795826 cites W2151440442 @default.
• W2070795826 cites W2152911432 @default.
• W2070795826 cites W2156862296 @default.
• W2070795826 cites W2165697122 @default.
• W2070795826 cites W2749679400 @default.
• W2070795826 cites W68282923 @default.
• W2070795826 cites W933886759 @default.
• W2070795826 doi "https://doi.org/10.1016/j.intimp.2011.07.009" @default.
• W2070795826 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3204179" @default.
• W2070795826 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21802529" @default.
• W2070795826 hasPublicationYear "2011" @default.
• W2070795826 type Work @default.
• W2070795826 sameAs 2070795826 @default.
• W2070795826 citedByCount "26" @default.
• W2070795826 countsByYear W20707958262012 @default.
• W2070795826 countsByYear W20707958262013 @default.
• W2070795826 countsByYear W20707958262014 @default.
• W2070795826 countsByYear W20707958262015 @default.
• W2070795826 countsByYear W20707958262016 @default.
• W2070795826 countsByYear W20707958262017 @default.
• W2070795826 countsByYear W20707958262018 @default.
• W2070795826 countsByYear W20707958262019 @default.
• W2070795826 countsByYear W20707958262020 @default.
• W2070795826 countsByYear W20707958262021 @default.
• W2070795826 countsByYear W20707958262022 @default.
• W2070795826 crossrefType "journal-article" @default.
• W2070795826 hasAuthorship W2070795826A5006062404 @default.
• W2070795826 hasAuthorship W2070795826A5015161312 @default.
• W2070795826 hasAuthorship W2070795826A5024499904 @default.
• W2070795826 hasAuthorship W2070795826A5024624450 @default.
• W2070795826 hasAuthorship W2070795826A5029632579 @default.
• W2070795826 hasAuthorship W2070795826A5034179357 @default.
• W2070795826 hasAuthorship W2070795826A5051281767 @default.
• W2070795826 hasBestOaLocation W20707958262 @default.
• W2070795826 hasConcept C126322002 @default.
• W2070795826 hasConcept C159654299 @default.
• W2070795826 hasConcept C203014093 @default.
• W2070795826 hasConcept C22070199 @default.
• W2070795826 hasConcept C2777701055 @default.
• W2070795826 hasConcept C2779547902 @default.
• W2070795826 hasConcept C2780441014 @default.
• W2070795826 hasConcept C2780801004 @default.
• W2070795826 hasConcept C542903549 @default.
• W2070795826 hasConcept C71924100 @default.
• W2070795826 hasConcept C8891405 @default.
• W2070795826 hasConcept C98274493 @default.
• W2070795826 hasConceptScore W2070795826C126322002 @default.
• W2070795826 hasConceptScore W2070795826C159654299 @default.
• W2070795826 hasConceptScore W2070795826C203014093 @default.
• W2070795826 hasConceptScore W2070795826C22070199 @default.
• W2070795826 hasConceptScore W2070795826C2777701055 @default.
• W2070795826 hasConceptScore W2070795826C2779547902 @default.
• W2070795826 hasConceptScore W2070795826C2780441014 @default.
• W2070795826 hasConceptScore W2070795826C2780801004 @default.
• W2070795826 hasConceptScore W2070795826C542903549 @default.
• W2070795826 hasConceptScore W2070795826C71924100 @default.
• W2070795826 hasConceptScore W2070795826C8891405 @default.
• W2070795826 hasConceptScore W2070795826C98274493 @default.
• W2070795826 hasIssue "11" @default.
• W2070795826 hasLocation W20707958261 @default.
• W2070795826 hasLocation W20707958262 @default.

• next